Based on the SMILES representation CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+], the molecule can be described as:
The molecule is a mixture of valproic acid and its sodium salt in a 1:1 molar ratio. It is used for the management and treatment of seizure disorders, mania, and prophylactic treatment of migraine headache. It has a role as an antimanic drug, an anticonvulsant and a GABA agent. It contains a valproic acid and a sodium valproate.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule can be described {#by|as!}:
{description#}
CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]
CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]
sodium;2-propylpentanoate;2-propylpentanoic acid
The molecule is a mixture of valproic acid and its sodium salt in a 1:1 molar ratio. It is used for the management and treatment of seizure disorders, mania, and prophylactic treatment of migraine headache. It has a role as an antimanic drug, an anticonvulsant and a GABA agent. It contains a valproic acid and a sodium valproate.